Chandigarh: Pulling up the Punjab govt for failing to meet its own deadline, the National Green Tribunal (NGT) has noted the ...

Hydrological data are typically sequential and often correspond to large datasets, and not all application programs allow their retrieval, storage, and manipulation. This technical article aims to ...

⁠India is a big importer of LPG and LNG and relies heavily on supplies from Middle Eastern countries such as Qatar. (AI image) Middle East conflict impact: What happens when the world's largest ...

PARIS — RAS Luxury Skincare, the Indian farm-to-face brand, closed a 65 Crores, or $7.5 million, Series B funding round led by Dabur Ventures. Dabur Ventures is the venture arm of the largest ...

Ras Kass returns with “Leopard Eats Face,” a feature-heavy Hip-Hop statement blending everything he is in one great project. AllHipHop caught up with a certified lyricist as he gears up for his latest ...

TJC LP (“TJC” or “the Firm”), a middle-market private equity firm investing primarily in North America, today announced that the Firm earned the #4 ranking on the HEC Paris-Dow Jones 2025 Global ...

Francisco Partners Ranks in Top Three of the HEC Paris-Dow Jones Annual Global Large Buyout Performance Ranking for Sixth Consecutive Year #2 ranking reflects consistent strong performance over the ...

A comprehensive, modular Python automation system for HEC-RAS flood analysis workflows. This professional-grade tool demonstrates advanced hydraulic modeling capabilities, Python integration, and ...

Bain Capital agreed to sell its data centers in China to Shenzhen Dongyangguang Industry Co. in a transaction valued at about $4 billion. Shenzhen Dongyangguang, the parent of Shanghai-listed ...

HEC Compuse Enterprise has gained full control of Poyun after its Hong Kong subsidiary, Honch Electronic, acquired all issued convertible bonds of Amber Investment Partners Limited (AIP), completing ...

Revolution Medicines has secured a potential funding infusion of up to $2 billion from Royalty Pharma in return for a slice of the profits if Revolution’s lead cancer drug makes it to market.